Concepts (180)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Genomics | 7 | 2023 | 5822 | 0.830 |
Why?
|
Genetic Privacy | 2 | 2012 | 59 | 0.790 |
Why?
|
Genetic Variation | 11 | 2024 | 6561 | 0.770 |
Why?
|
Computer Security | 3 | 2012 | 260 | 0.660 |
Why?
|
Population Surveillance | 5 | 2008 | 2595 | 0.650 |
Why?
|
Medical Record Linkage | 2 | 2012 | 286 | 0.630 |
Why?
|
BRCA1 Protein | 1 | 2024 | 1149 | 0.590 |
Why?
|
Computational Biology | 4 | 2018 | 3509 | 0.570 |
Why?
|
Genetic Association Studies | 2 | 2017 | 2734 | 0.550 |
Why?
|
Selection, Genetic | 3 | 2019 | 868 | 0.550 |
Why?
|
CCN Intercellular Signaling Proteins | 1 | 2015 | 24 | 0.520 |
Why?
|
Public Health Informatics | 2 | 2008 | 109 | 0.520 |
Why?
|
Geographic Information Systems | 4 | 2008 | 281 | 0.430 |
Why?
|
Gene Frequency | 3 | 2017 | 3601 | 0.430 |
Why?
|
Sequence Analysis, DNA | 5 | 2023 | 4739 | 0.430 |
Why?
|
Genome-Wide Association Study | 5 | 2022 | 12661 | 0.420 |
Why?
|
Mutation, Missense | 4 | 2024 | 2570 | 0.410 |
Why?
|
DNA Fingerprinting | 1 | 2012 | 114 | 0.410 |
Why?
|
Genetic Predisposition to Disease | 8 | 2023 | 17878 | 0.400 |
Why?
|
Information Dissemination | 2 | 2012 | 1125 | 0.400 |
Why?
|
Genetic Testing | 3 | 2023 | 3533 | 0.400 |
Why?
|
Databases, Nucleic Acid | 1 | 2012 | 205 | 0.380 |
Why?
|
Joint Diseases | 1 | 2015 | 459 | 0.380 |
Why?
|
Disease Outbreaks | 3 | 2005 | 1748 | 0.380 |
Why?
|
Databases, Genetic | 5 | 2018 | 1742 | 0.360 |
Why?
|
Rare Diseases | 1 | 2015 | 622 | 0.340 |
Why?
|
Confidentiality | 4 | 2008 | 608 | 0.340 |
Why?
|
Privacy | 2 | 2008 | 233 | 0.320 |
Why?
|
Epidemiologic Measurements | 2 | 2005 | 23 | 0.310 |
Why?
|
Security Measures | 1 | 2008 | 82 | 0.300 |
Why?
|
Heterozygote | 4 | 2020 | 2780 | 0.280 |
Why?
|
Community Networks | 1 | 2008 | 201 | 0.280 |
Why?
|
Algorithms | 8 | 2019 | 14018 | 0.260 |
Why?
|
Disclosure | 1 | 2012 | 747 | 0.260 |
Why?
|
Penetrance | 2 | 2020 | 382 | 0.250 |
Why?
|
Receptors, LDL | 2 | 2024 | 488 | 0.240 |
Why?
|
Bioterrorism | 1 | 2005 | 144 | 0.240 |
Why?
|
Epidemiologic Methods | 1 | 2008 | 1335 | 0.220 |
Why?
|
Interdisciplinary Communication | 1 | 2008 | 928 | 0.210 |
Why?
|
Cluster Analysis | 3 | 2008 | 2700 | 0.200 |
Why?
|
Qa-SNARE Proteins | 1 | 2021 | 52 | 0.190 |
Why?
|
Phenotype | 5 | 2024 | 16571 | 0.190 |
Why?
|
Medical Records Systems, Computerized | 1 | 2007 | 1191 | 0.190 |
Why?
|
Bardet-Biedl Syndrome | 1 | 2020 | 51 | 0.170 |
Why?
|
Genotype | 3 | 2024 | 12978 | 0.170 |
Why?
|
Prenylation | 1 | 2019 | 37 | 0.170 |
Why?
|
Models, Genetic | 3 | 2019 | 3431 | 0.170 |
Why?
|
Genetic Drift | 1 | 2019 | 41 | 0.170 |
Why?
|
Pathology, Molecular | 1 | 2022 | 329 | 0.170 |
Why?
|
Immune System Diseases | 1 | 2021 | 254 | 0.160 |
Why?
|
Menkes Kinky Hair Syndrome | 1 | 2018 | 19 | 0.160 |
Why?
|
Hermanski-Pudlak Syndrome | 1 | 2018 | 20 | 0.160 |
Why?
|
Benchmarking | 1 | 2005 | 1045 | 0.160 |
Why?
|
Templates, Genetic | 1 | 2018 | 189 | 0.160 |
Why?
|
BRCA2 Protein | 1 | 2023 | 797 | 0.150 |
Why?
|
RNA Splicing | 1 | 2022 | 898 | 0.150 |
Why?
|
Codon, Nonsense | 1 | 2019 | 284 | 0.150 |
Why?
|
rab GTP-Binding Proteins | 1 | 2019 | 250 | 0.150 |
Why?
|
Disease | 2 | 2015 | 670 | 0.140 |
Why?
|
Normal Distribution | 2 | 2008 | 272 | 0.140 |
Why?
|
Bayes Theorem | 3 | 2024 | 2326 | 0.130 |
Why?
|
Journal Impact Factor | 1 | 2018 | 153 | 0.130 |
Why?
|
Breast Neoplasms | 2 | 2023 | 20988 | 0.130 |
Why?
|
Protein-Lysine 6-Oxidase | 1 | 2016 | 55 | 0.130 |
Why?
|
Multifactorial Inheritance | 2 | 2022 | 1380 | 0.130 |
Why?
|
Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2020 | 380 | 0.130 |
Why?
|
Humans | 37 | 2024 | 760617 | 0.120 |
Why?
|
Hearing Loss, Sensorineural | 1 | 2021 | 781 | 0.120 |
Why?
|
Suppression, Genetic | 1 | 2015 | 190 | 0.120 |
Why?
|
Hyperlipoproteinemia Type II | 1 | 2020 | 395 | 0.120 |
Why?
|
Quantitative Trait Loci | 1 | 2022 | 2112 | 0.120 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2024 | 2917 | 0.110 |
Why?
|
Computer Simulation | 2 | 2015 | 6233 | 0.110 |
Why?
|
Population Dynamics | 1 | 2015 | 306 | 0.110 |
Why?
|
False Positive Reactions | 1 | 2015 | 957 | 0.110 |
Why?
|
Genes, Dominant | 1 | 2015 | 851 | 0.100 |
Why?
|
Models, Theoretical | 1 | 2004 | 3567 | 0.100 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2019 | 1745 | 0.090 |
Why?
|
Software | 2 | 2019 | 4431 | 0.090 |
Why?
|
Germ-Line Mutation | 1 | 2019 | 1852 | 0.090 |
Why?
|
Pedigree | 4 | 2020 | 4539 | 0.090 |
Why?
|
Genetic Research | 1 | 2012 | 171 | 0.090 |
Why?
|
Peer Review, Research | 1 | 2014 | 339 | 0.090 |
Why?
|
Early Diagnosis | 1 | 2015 | 1185 | 0.090 |
Why?
|
Genetics, Population | 1 | 2015 | 935 | 0.090 |
Why?
|
Ethics, Research | 1 | 2012 | 176 | 0.090 |
Why?
|
Maps as Topic | 2 | 2006 | 18 | 0.090 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2016 | 696 | 0.080 |
Why?
|
Needs Assessment | 1 | 2015 | 1139 | 0.080 |
Why?
|
Forecasting | 1 | 2018 | 2924 | 0.080 |
Why?
|
Homozygote | 1 | 2013 | 1776 | 0.080 |
Why?
|
Incidental Findings | 1 | 2013 | 697 | 0.080 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2019 | 1727 | 0.080 |
Why?
|
Carcinoma | 1 | 2019 | 2327 | 0.070 |
Why?
|
Genome, Human | 3 | 2020 | 4421 | 0.070 |
Why?
|
Genetic Counseling | 1 | 2012 | 627 | 0.070 |
Why?
|
Gene Library | 2 | 2021 | 1055 | 0.070 |
Why?
|
Information Services | 1 | 2008 | 236 | 0.070 |
Why?
|
Geography | 2 | 2008 | 652 | 0.070 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2021 | 2423 | 0.070 |
Why?
|
Systems Integration | 1 | 2007 | 426 | 0.060 |
Why?
|
State Government | 1 | 2008 | 384 | 0.060 |
Why?
|
Cohort Studies | 3 | 2023 | 41457 | 0.060 |
Why?
|
Software Design | 1 | 2005 | 171 | 0.060 |
Why?
|
Markov Chains | 1 | 2008 | 965 | 0.060 |
Why?
|
Mice, Knockout | 2 | 2017 | 14389 | 0.060 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2017 | 3634 | 0.060 |
Why?
|
Alleles | 3 | 2020 | 6861 | 0.050 |
Why?
|
HEK293 Cells | 2 | 2024 | 4269 | 0.050 |
Why?
|
Evaluation Studies as Topic | 1 | 2004 | 1623 | 0.050 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2022 | 15908 | 0.050 |
Why?
|
Pancreatic Neoplasms | 1 | 2019 | 5367 | 0.050 |
Why?
|
Point Mutation | 2 | 2020 | 1595 | 0.050 |
Why?
|
Population Growth | 1 | 2019 | 50 | 0.040 |
Why?
|
Sequence Homology | 1 | 2019 | 196 | 0.040 |
Why?
|
Reproducibility of Results | 2 | 2018 | 20074 | 0.040 |
Why?
|
Animals | 7 | 2021 | 168201 | 0.040 |
Why?
|
HCT116 Cells | 1 | 2018 | 403 | 0.040 |
Why?
|
Severity of Illness Index | 1 | 2015 | 15828 | 0.040 |
Why?
|
K562 Cells | 1 | 2018 | 641 | 0.030 |
Why?
|
Epigenomics | 1 | 2022 | 942 | 0.030 |
Why?
|
Base Sequence | 2 | 2018 | 12421 | 0.030 |
Why?
|
Massachusetts | 1 | 2008 | 8833 | 0.030 |
Why?
|
Electronic Health Records | 1 | 2012 | 4803 | 0.030 |
Why?
|
Decision Support Techniques | 1 | 2005 | 1998 | 0.030 |
Why?
|
Female | 7 | 2023 | 392148 | 0.030 |
Why?
|
Exons | 1 | 2021 | 2381 | 0.030 |
Why?
|
Age of Onset | 1 | 2021 | 3302 | 0.030 |
Why?
|
Substrate Specificity | 1 | 2018 | 1790 | 0.030 |
Why?
|
Communication | 1 | 2008 | 3849 | 0.030 |
Why?
|
Emergency Medical Services | 1 | 2005 | 1921 | 0.030 |
Why?
|
Risk Assessment | 1 | 2015 | 23972 | 0.030 |
Why?
|
Time Factors | 1 | 2015 | 39913 | 0.030 |
Why?
|
Embryonic Stem Cells | 1 | 2021 | 1262 | 0.030 |
Why?
|
Myopathies, Structural, Congenital | 1 | 2014 | 103 | 0.030 |
Why?
|
Male | 7 | 2021 | 360358 | 0.030 |
Why?
|
Immediate-Early Proteins | 1 | 2015 | 444 | 0.030 |
Why?
|
Financing, Organized | 1 | 2014 | 204 | 0.030 |
Why?
|
Mutation | 1 | 2017 | 30016 | 0.030 |
Why?
|
Family Health | 1 | 2016 | 1253 | 0.020 |
Why?
|
Microcephaly | 1 | 2015 | 425 | 0.020 |
Why?
|
Sequence Alignment | 1 | 2015 | 2178 | 0.020 |
Why?
|
Microtubule-Associated Proteins | 1 | 2015 | 1074 | 0.020 |
Why?
|
United States | 2 | 2023 | 72272 | 0.020 |
Why?
|
Biological Evolution | 1 | 2015 | 1070 | 0.020 |
Why?
|
DNA Repair | 1 | 2018 | 2043 | 0.020 |
Why?
|
Codon | 1 | 2011 | 600 | 0.020 |
Why?
|
Molecular Sequence Annotation | 1 | 2011 | 520 | 0.020 |
Why?
|
Fibroblasts | 1 | 2018 | 4137 | 0.020 |
Why?
|
Population Density | 1 | 2008 | 193 | 0.020 |
Why?
|
Odds Ratio | 1 | 2020 | 9643 | 0.020 |
Why?
|
Zebrafish | 1 | 2019 | 3007 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2020 | 22148 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2016 | 4110 | 0.020 |
Why?
|
Adult | 3 | 2019 | 220969 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2019 | 13441 | 0.020 |
Why?
|
Evolution, Molecular | 1 | 2015 | 1880 | 0.020 |
Why?
|
Aged | 4 | 2020 | 169042 | 0.020 |
Why?
|
Amino Acid Substitution | 1 | 2011 | 1739 | 0.020 |
Why?
|
New York | 1 | 2008 | 874 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2020 | 12447 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2021 | 18937 | 0.020 |
Why?
|
Tumor Suppressor Proteins | 1 | 2015 | 2801 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2015 | 2895 | 0.010 |
Why?
|
Middle Aged | 4 | 2020 | 220584 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2019 | 10432 | 0.010 |
Why?
|
Mice | 2 | 2021 | 81368 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2021 | 26180 | 0.010 |
Why?
|
Models, Statistical | 1 | 2015 | 5073 | 0.010 |
Why?
|
Coronary Artery Disease | 1 | 2020 | 6403 | 0.010 |
Why?
|
Colorectal Neoplasms | 1 | 2020 | 6925 | 0.010 |
Why?
|
Proteins | 1 | 2015 | 6030 | 0.010 |
Why?
|
Medical Records | 1 | 2005 | 1407 | 0.010 |
Why?
|
Linear Models | 1 | 2008 | 5866 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2016 | 22115 | 0.010 |
Why?
|
Heart Defects, Congenital | 1 | 2014 | 4671 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2019 | 58894 | 0.010 |
Why?
|
Boston | 1 | 2006 | 9313 | 0.010 |
Why?
|
Risk Factors | 1 | 2020 | 74115 | 0.010 |
Why?
|
Child | 1 | 2014 | 80079 | 0.000 |
Why?
|
Concepts
(180)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(71)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_